Bifidobacterium infantis 35624 modulates host inflammatory processes beyond the gut
(FDA emideltide/DSIP note) Semax (neurology indications) Semax is evaluated for cerebral ischemia, migraine, and trigeminal neuralgia
Whether peptide-induced improvements in allergic disease persist after discontinuation, and for how long, is an open question for most peptides (except allergen-derived peptide immunotherapy, which does have multi-year follow-up data)
Instead of simply dampening inflammation, the goal is structural repair
Preclinical research suggests it interacts with GABAergic and HPA-axis-linked signaling, making it a central tool for investigations related to sleep disorders, stress management, and neuropeptide modulation under defined experimental conditions